Navigation Links
Parexel Invites Public To Listen To Live Webcast Of Its Investor Day May 31, 2012
Date:5/17/2012

BOSTON, May 17, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day on Thursday, May 31, 2012, from 8:30 a.m. to 12:30 p.m. (EDT).

All interested parties are invited to listen as Chairman and Chief Executive Officer Josef von Rickenbach, Chief Financial Officer Jim Winschel and five additional members of the executive team provide a strategic overview of the Company's businesses through a series of presentations, followed by a question-and-answer session.

The live webcast will be accessible in the Investor Relations section of the Company's website at www.PAREXEL.com.  For those unable to listen to the live presentations, the event will be archived and available on the Company's website.

About PAREXEL International

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.  Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process.  Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 50 countries around the world, and has approximately 11,920 employees. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.

 

CONTACT: Jill Baker, Corporate Vice President of Investor Relations
+1-781-434-4118

 

 

 


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
2. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
3. PAREXEL Announces Date of Third Quarter Fiscal Year 2012 Earnings Release and Conference Call
4. PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting
5. PAREXEL Global Survey Results Identify Top Concerns of Biopharma Industry in Achieving Commercial Success
6. PAREXEL International to Present at Barclays Capital Healthcare Conference
7. PAREXEL International to Present at Cowen Healthcare Conference and Raymond James Investors Conference
8. PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives
9. PAREXEL Expands Alliance Network to Support Early Phase Patient Studies, Establishes Collaboration With University Hospitals Bristol NHS Foundation Trust
10. PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call
11. PAREXEL Strengthens Late Phase and Observational Research Capabilities With Expert Team to Help Biopharma Meet Commercialization Goals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25, 2016 Digital Health ... to it by the US Patent and Trademark ... technology includes proprietary processes for electronic opt-­in and ... and wellness programs, HIPAA compliance and otherwise. ... "Our technology allows for ...
(Date:5/25/2016)... PUNE, India , May 25, 2016 /PRNewswire/ ... Pipeline Review, H1 2016"market research report that provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und ... Überlegenheit in ‚ausgezeichneter plus guter ... Colons    ,      (Logo: ... gab heute neue positive Daten von der MORA-Studie ...
Breaking Medicine Technology:
(Date:5/26/2016)... New Hampshire (PRWEB) , ... May 26, 2016 , ... ... which are designed, engineered, and manufactured in Warner, New Hampshire at the MadgeTech headquarters. ... to provide reliable monitoring solutions trusted by government agencies, including NASA. , In ...
(Date:5/26/2016)... ... 2016 , ... Memorial Day Weekend marks the unofficial start of summer and ... to make sure your family and vehicle are ready to hit the road this ... 439 deaths and an additional 50,500 serious injuries from motor vehicle crashes during the ...
(Date:5/26/2016)... ... May 26, 2016 , ... Nike Yoga Camps ... from daily practices, arts & crafts, discussions, and games all geared towards enhancing ... Evans have combined backgrounds in kids’ yoga, collegiate sport yoga instruction, and global ...
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... ... (also knowns as a bunionette) treatment was more than humbled by customer demand over ... one of their SKU's mid sale. Now that Bunion Bootie has completely replenished its ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... provide strategic sales leadership and to further develop their rapidly expanding portfolio of ... Business Administration with a concentration in Marketing and an M.B.A. with concentration in ...
Breaking Medicine News(10 mins):